Jagsonpal Pharmaceuticals Ltd
Ticker: JAGSNPHARM
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
222.87
Market Cap
1487.09
Debt/Equity
0.0385
ROE %
25.913
PB
6.1975
Promoter %
67.649
Pledge %
0.000
1Y Rev Growth %
37.751
5Y Rev Growth %
13.262
NP Margin %
18.440
NP Margin 5Y Avg %
11.431
Trading Reference
1M Return %
-12.389
6M Return %
1.586
1Y Return %
22.672
% Away 52W High
47.189
% Away 52W Low
27.223
Daily Volume
103278
Investment Verdict
Hold
Score 64/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 24/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Jagsonpal Pharmaceuticals Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is a potential for significant upside. However, if it falls below the support, downside risk increases.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Asian Energy Services Ltd
Asian Energy Services Ltd shows potential in a future-ready sector but faces challenges in growth consistency and valuation metrics.
View details
A
Andhra Paper Ltd
Andhra Paper Ltd shows potential but faces challenges in growth consistency and market competition.
View details
R
Roto Pumps Ltd
Roto Pumps Ltd shows several weaknesses in growth, profitability, and market sentiment, indicating a risky investment.
View details
S
Shriram Properties Ltd
While Shriram Properties Ltd has potential in a growing sector, inconsistencies in financial performance and valuation concerns warrant caution.
View details
M
MM Forgings Ltd
MM Forgings Ltd shows a decent investment potential with consistent growth and profitability metrics, but some risks in governance and execution should be monitored.
View details
D
DAM Capital Advisors Ltd
DAM Capital Advisors Ltd shows a decent investment potential with a solid business model and consistent growth, but attention should be paid to liquidity and execution risks.
View details
J
Jagran Prakashan Ltd
Jagran Prakashan Ltd shows potential in a transitioning media landscape but faces challenges in growth consistency and valuation metrics.
View details
E
Everest Kanto Cylinder Ltd
The stock presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised.
View details
S
Salasar Techno Engineering Ltd
Salasar Techno Engineering Ltd shows potential for growth but faces challenges in profitability and execution risks. Investors should be cautious.
View details
E
Elpro International Ltd
Elpro International Ltd shows some potential but faces challenges in growth consistency and market sentiment.
View details
S
Signpost India Ltd
Signpost India Ltd has potential but faces significant challenges in growth and profitability metrics.
View details
I
Igarashi Motors India Ltd
Igarashi Motors shows potential in a growing sector, but faces challenges in consistency and valuation.
View details
V
Vinyas Innovative Technologies Ltd
Vinyas Innovative Technologies Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
U
Unicommerce eSolutions Ltd
Unicommerce eSolutions Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
View details
V
Virtuoso Optoelectronics Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
P
Punjab Chemicals and Crop Protection Ltd
Punjab Chemicals and Crop Protection Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
Business Overview
Jagsonpal Pharmaceuticals Ltd is a prominent player in the Indian pharmaceutical sector, dedicated to enhancing healthcare through innovative products. Catering to diverse therapeutic areas, it serves healthcare professionals and patients alike. The company is committed to quality, affordability, and accessibility, making a significant impact on public health. With a robust portfolio and a strong distribution network, Jagsonpal is well-positioned to meet the growing demands of the Indian market.
- Established reputation in the Indian pharmaceutical industry
- Wide range of therapeutic products
- Focus on quality and affordability
- Strong distribution network across India
- Commitment to improving public health
Investment Thesis
Jagsonpal Pharmaceuticals Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and enhanced shareholder value, making it a compelling investment opportunity.
- Strong promoter group with a proven track record in the pharmaceutical sector.
- Significant growth potential in digital services, aligning with industry trends.
- Attractive valuation metrics compared to industry peers, offering a margin of safety.
- Established brand presence and distribution network enhancing market reach.
- Commitment to innovation and quality, ensuring long-term competitiveness.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong product pipeline
- Partnerships with healthcare providers
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in pharmaceuticals
- Dependence on key products
- Market volatility impacting sales
Peer Perspective
Jagsonpal Pharmaceuticals Ltd trades at a discount to peers like Sun Pharmaceutical and Cipla, with a focus on improving margin stability. A successful acceleration in growth could trigger a rerating in its valuation.
Future Outlook
Jagsonpal Pharmaceuticals Ltd is well-positioned for growth, driven by its robust product pipeline and market expansion. Successful execution and diligent cost control will be crucial to maximizing shareholder value in the coming years.
AI FAQs for Retail Users
- Q: What does Jagsonpal Pharmaceuticals Ltd do?A: Jagsonpal Pharmaceuticals Ltd is involved in manufacturing and marketing pharmaceutical products in India.
- Q: Is Jagsonpal Pharmaceuticals Ltd a good investment?A: Investment decisions should be based on thorough research and personal financial goals.
- Q: What are the risks of investing in this stock?A: Market volatility, regulatory changes, and company performance can affect stock value.
- Q: How can I buy shares of Jagsonpal Pharmaceuticals Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: What is the company's dividend policy?A: Dividend policies may vary; check the latest announcements for current information.
📊 Stock Investment Checklist (100 Points)
Jagsonpal Pharmaceuticals Ltd • Updated: 2025-09-17 02:50:47
-
10BusinessHighPharmaceutical sector is essential but faces regulatory challenges.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
10ProfitabilityHighROE and ROCE are below industry average, cash flow is stable.
-
8ValuationHighP/E and P/B ratios are higher than peers, indicating overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth drivers identified, execution risks are high.
-
5TechnicalsGoodWeak market sentiment and low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Jagsonpal Pharmaceuticals Ltd shows potential but faces significant challenges in profitability and valuation metrics. Caution is advised for investors.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 65/100